Your SlideShare is downloading. ×
Clinical Research Presentation
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Clinical Research Presentation

7,379
views

Published on

my first presentation on clinical research and its carrier opportunities

my first presentation on clinical research and its carrier opportunities


2 Comments
2 Likes
Statistics
Notes
No Downloads
Views
Total Views
7,379
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
170
Comments
2
Likes
2
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. WELCOME
  • 2. What is clinical research? ‘ CLINICAL’ means: ‘Treatment of patients’ ‘ RESEARCH’ means: ‘Systematic investigation & study in order to establish facts & reach new conclusions’
  • 3.
    • A clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions.
    • Carefully conducted clinical trials are the safest and fastest way to find treatments that work in people and ways to improve health.
    • Clinical trials are the final step in a long research process that include preliminary laboratory research and experiment.
  • 4. Types of clinical trial
    • Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments.
    • Observational trials address health issues in large groups of people or populations in natural settings.
  • 5. Phases of drug development
    • Identification of new molecule
    • Screening of biological activity/experiment design
    • Preformulation
    • Formulation
    • Stability testing.
  • 6. Phases of Drug Development
    • Steps prior to human trials:
    • Preclinical (nonclinical).
        • Animal and in vitro studies.
    • A study to test a drug procedure or other medical treatment in animals. Preclinical studies are required before clinical trials can be started.
    • Investigational new drug application (IND) or Investigational device exemption (IDE) for the FDA
  • 7. Basis for phased drug development
    • Safety
    • Pharmacology
    • Efficacy
  • 8. Phases of Drug Development
    • Phase 1:
      • First studies in human.
      • Usually involve small groups of healthy volunteers or patients with particular disease – 20 - 80.
      • Short duration.
      • Provide preliminary safety and tolerability evaluation.
      • Establish pharmacokinetic and pharmacodynamic profiles of the drug
  • 9. Phases of Drug Development
      • Evaluate efficacy and short-term safety of the drug.
      • small groups of patients with disease under study.
      • 100-300 subjects
      • Have well defined eligibility criteria
      • Determine dosing
      • Duration –couple of months to 2 years
    Phase 2:
  • 10. Phases of Drug Development
    • Phase 3
      • Larger, well-controlled trials with larger groups of subjects.
      • Eligibility criteria usually broader
      • Simulate the actual treatment condition
      • Establishes safety and efficacy profile in broad sample.
      • Results used in marketing application and official product labeling.
  • 11. Phases of Drug Development
    • Phase 4:
        • Conducted after marketing approval of drug.
    • -Post marketing studies sometimes designed to differentiate the drug from competitors and demonstrate health economic benefits.
        • Include post registration usage studies and post-marketing surveillance studies.
  • 12. Key stake holders
    • Study sponsor
    • Investigator and site personnel
    • Monitors
    • IRB/IEC
    • Study subjects
    • Hospital administration
    • Regulator
  • 13. Key documents in Clinical research
    • Investigators brochure
    • Study protocol
    • Informed consent form
    • Case report form
    • Source documents
    • Clinical study report
  • 14. International Conference on Harmonisation
    • Agreement between the united states, Japan and European Union
    • Describes Good Clinical Practices
    • The main agenda of ICH-GCP is to protect human subjects and ensure credibility of data
  • 15. Why Career in Clinical Research?
    • Fastest growing segment in the healthcare / pharmaceutical industry
    • Excellent Opportunity to Develop Combination of Technical and Management Skill Development
    • Part of the Global Growth Opportunity
    • Wider Job Horizon
    • Rapidly Growing Opportunities… (internal and external)
    • Higher Salaries
    • Higher Job Satisfaction
    • Continuous Training Opportunities
    • Overseas Job Opportunities
  • 16. India –Hub of global clinical research
    • India is one of the top 3 countries where companies plan to spend the most R&D dollars over the next three years
    • Over 30 CRO’s offer phase 1 to 4 trials complying with ICH-GCP guidelines
    • Over US$500 million FDI expected in the next 18months
    • With 100 hospitals serving as sites for clinical trials ,India is emerging as one of the fastest recruiter of subjects across the world.
  • 17. Advantages of India
    • The clinical community populated with English speaking ,western –trained graduates
    • Sophisticated technological infrastructure
    • 100 million plus English speaking /trained professionals
    • Over 2 million science graduates
    • Large pool of treatment naïve patients from multiethnic and multiracial backgrounds
    • Better patient recruitment, retention and compliance
  • 18.
    • Cost effective operations
    • Participants generally benefit ,as the trials conducted in India mostly in phase 2 -4, provide improved care and cost savings as procedures and drugs are provided at no charge
    • Higher GMP/GLP/GCP compliance
    • Maximum number of approved GMP plants outside USA
    • Excellent quality management ,technology and infrastructure
    • Increasing presence of all pharma majors ,CROs and also in-house CROs set up by leading pharma companies
    • Strong IT industry availability of IT skilled manpower
  • 19. Regulatory frame work
    • Positive regulatory environment –protocols approved by DCGI/ Schedule Y
    • CDSCO (Central Drugs Standard Control Organization) to regulate Clinical research
    • Further strengthening of environment by setting up National Drug Authority
    • Intellectual property protection
        • As of January 2005 ,recognize product patents from 1995 to present
    • Clinical trial protocol time is reducing
    • Duty free import of clinical trial supplies
    • Easier drug importation procedure
    • ICMR guidelines on the safety of Human Subjects
  • 20. India’s vital clinical statistics
    • Cancer : 3 million
    • Diabetes : 34 million
    • HIV : 8-10 million
    • Epilepsy : 8 million
    • Hypertension : 150 million
    • Schizophrenia : 1 million
    • Asthma : 40 million
    • Alzheimer’s : 1.5 million
    • Cardiac related deaths : 2 million
    • Recruits for genetic studies
    • 600,000 practicing physicians
    • 14,000 hospitals
    • 700,000 beds
    • 17,000 medical graduates per year
  • 21. Indian Market For Clinical Research
    • 2002 Industry Spending on
    • CRO Services and Investigator Grants $30 million
    • Market Size in 2005-06 $200 million
    • Estimated Market Size in 2007 $450 million
    • Estimated Market Size in 2008 $600 million
    • 2012Projected Industry Spending on
    • CRO Services and Investigator Grants $2 billion
  • 22. Some Pharma Companies in Clinical Research
    • Chiron, Mumbai
    • Astra Zeneca Pharma India Ltd, Bangalore
    • Astra Zeneca Foundation, Bangalore
    • AventisPasteur, Delhi
    • Pfizer Ltd, Mumbai
    • Pfizer Biometrics, Mumbai
    • Altana(Zydus), Mumbai
    • Eli Lilly, Delhi
    • Boston Scientific, Delhi
    • Hospira, Delhi
    • Merck ,Delhi
    • Sanofi Aventis Syntho Lab, Mumbai
    • GSK, Glaxo SmithKline Pharmaceuticals Ltd,Mumbai
    • Novartis International Clinical Development Center,
    • Novartis Pharma, Mumbai
    • Roche,Mumbai
  • 23. Key CROs in India Quintiles Ahmadabad / Bangalore Synchron Ahmedabad /Bangalore Lambda Ahmedabad Siro Clinpharm Mumbai I-Gate Mumbai Reliance Clinical Services Mumbai PPD Mumbai Onmnicare Bangalore ICON Bangalore Clin Trac Bangalore PharmaNet Bangalore Pharm-Olam Bangalore Lotus Labs Bangalore Vimta Hyderabad GVK Hyderabad BioServe Clinical Research Hyderabad Apothecaries Delhi
  • 24. Types of Jobs
    • Clinical Monitors / CRAs
    • Clinical Research Coordinators / Site Coordinators
    • Drug Safety Personnel
    • Project Personnel
    • Medical Monitors
    • Regulatory Affairs Monitors
    • Medical Writers
    • Quality Control / Assurance Personnel
    • Data Management Personnel
    • Statisticians
    • Scientists
    • Lab Personnel
    • Management & Support Personnel
  • 25. Types of Employers
    • Pharmaceutical Companies
    • Contract Research Organization
    • Hospitals
    • Non Government Organization
    • WHO
  • 26. Key cities in India for clinical research
    • Delhi &NCR Region
    • Mumbai
    • Pune
    • Ahmedabad
    • Hyderabad
    • Bangalore
    • Chennai
  • 27. Challenges of current CR Industry
    • Major gap in Demand & Supply of trained manpower – An unmet need
    • By 2012 Indian market would be over US$2 billion, and would continue to grow at rapid pace.
    • Over 75 CROs & 60 In-house Pharmaceutical Clinical Research & R&D Facilities in India and increasing
    • Current trained manpower demand in the field of Clinical Research is over 10,000 trained personnel per annum.
  • 28.
    • By 2012 over 50,000 certified/trained professionals will be required.
    • The current facilities are able to train only 1,500 professionals.
    • Employers required well trained professionals.
    • very rapid growth in number and size of company
    • Lack of specialization
    • Spectrum of skills required is in scarcity
    • Limited pool of experienced people
    • Employee retention
    • Continuous training
  • 29. CLINIMINDS
  • 30. “ Committed to provide highest quality training ,education &management solutions and develop superior human resource for the global clinical research industry”.
  • 31. About Cliniminds
    • Cliniminds was established in the year 2004 by a group of Senior Professionals from Pharmaceutical, Clinical Research & Healthcare industry.
    • Two brands – Cliniminds & Mediminds were established to provide vocational and professional education and training in the clinical research, healthcare & pharmaceutical areas.
    • To provide opportunities to fresh graduates or working executives aspiring to build career in the booming Clinical Research / Healthcare/ Pharmaceutical industry.
    • To provide continuing education, Professional development, and vocational skills enhancement Programs for Clinical Research / Healthcare / Pharmaceutical professionals
  • 32. Features of Cliniminds
    • Cliniminds is an innovative training company providing a wide range of clinical research training solutions to the students, pharmaceutical companies, CRO s and healthcare companies in India and other part of the world
    • Cliniminds-Academy for clinical research training and management, offers wide range of full time, part time, class room, online and distance learning certificate /diploma programs, workshops &seminars
    • Cliniminds can help to achieve the level of expertise required , through user-friendly and cost effective training programs
    • Restricted number of students
    • 100 % placement assistance to all students
    • All Cliniminds programs are certified and accredited by the Pharmaceutical society of India and Cliniminds (ISO 9001/2000 certified academy) jointly.
  • 33. Cliniminds Key Team Members
      • Kamal Shahani – Consultant/Industry expert/Trainer
      • Dr. Srinkant Tadipatri, Clinical Research Specialist from United States, ex Pfizer
      • Dr. Suneet Sood, Professor, leading international medical school
      • Dr. U. Kapoor, Senior Manager, Clinical Research
      • Dr. Deepak Bunger, Clinical Investigator, PGI
      • Dr. Amit Bhatt, CEO, Nexus CRO
      • Mr. Vatsal Acharya, Industry Specialist from leading MNC
      • Dr. G.S. Arora, Industry Specialist from leading MNC & Former Professor of Clinical Research
      • Dr. Ramesh C, Princpal, Pharmacy College, Hyderabad
      • Ms. Pooja Saxena, Senior CRA, leading CRA
  • 34. Our Core Areas
    • Clinical Research/Medical/Healthcare Educational Training Programs
    • Course Content Development
    • Management Development Programs
    • Placement Services
    • Business & Consulting Services
  • 35. Programs offered by Cliniminds
    • Classroom Programs, Distance & Online
    • Advance Post Graduate Program in Clinical Research
    • Post Graduate Program in Clinical Trial Management
    • Post Graduate Program in Clinical Data Management
  • 36. Distance & On - Line Programs
    • Post Graduate Diploma in Clinical Trial Management
    • Advanced Post Graduate program in Clinical Research
    • Certified program in Clinical Research
    • Post graduate program in Clinical Data Management
    • Post Graduate program in Pharmacovigilence
    • Post graduate program in Conducting &Managing BA/BE studies
    • Certificate Program in Conducting & Managing Clinical Trials for Cancer Patients
    • Post Graduate program in Quality assurance in clinical research
    • Post graduate program in Regulatory Affairs
    • Post graduate program in clinical research for nurses
    • Post Graduate Program for Investigators & Site Personnel
    • Post Graduate Program for CRAs/Monitors
  • 37. E-Learning Programs-Video Conference Class
    • Advanced PG Program in Clinical Research
    • PG Program in Basics of Biostatistics
  • 38. Workshops &corporate trainings
    • Cliniminds conducts regular interactive workshops on clinical research on regular basis
    • Providing in house training solution for corporates
    • Certificates are provided at the end of the workshops
    • Cost efficient –value for money
    • Customization of workshops as per client needs
  • 39. Eligiblity
    • All from Science backgrounds
    • MD,MS,MBBS,BDS,BHMS,BAMS,Grad-uate /Post Graduate Degree in Science, Pharmacology, Pharmacy, Life sciences , Medical laboratory ,Nursing, Biochemistry, Microbiology ,Biotechnology.
    • All professionals working with Pharmaceutical companies or CROs
  • 40. Methodology
    • Regular classes
    • Printed training modules
    • Workshops
    • Web based testing and examinations
    • Onsite training
    • ICH GCP guidelines and covers schedule Y and CFR 21 compliant programs
  • 41. Educational loans –HDFC Bank
    • All our programs have been approved by the HDFC BANK for the purpose of educational loans for the students
  • 42. Cliniminds (Unit of Tenet Health Edutech Pvt. Ltd. ) No. 420, 1st Floor, 9th Main, Banashankari 2nd Stage, Bangalore - 560070 Mobile: +91-96636-91388 Email : bangalore @cliniminds.com Website : http://www.cliniminds.com
  • 43. Thank you

×